Literature DB >> 21310295

RNA editing by mammalian ADARs.

Marion Hogg1, Simona Paro, Liam P Keegan, Mary A O'Connell.   

Abstract

The main type of RNA editing in mammals is the conversion of adenosine to inosine which is translated as if it were guanosine. The enzymes that catalyze this reaction are ADARs (adenosine deaminases that act on RNA), of which there are four in mammals, two of which are catalytically inactive. ADARs edit transcripts that encode proteins expressed mainly in the CNS and editing is crucial to maintain a correctly functioning nervous system. However, the majority of editing has been found in transcripts encoding Alu repeat elements and the biological role of this editing remains a mystery. This chapter describes in detail the different ADAR enzymes and the phenotype of animals that are deficient in their activity. Besides being enzymes, ADARs are also double-stranded RNA-binding proteins, so by binding alone they can interfere with other processes such as RNA interference. Lack of editing by ADARs has been implicated in disorders such as forebrain ischemia and Amyotrophic Lateral Sclerosis (ALS) and this will also be discussed.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21310295     DOI: 10.1016/B978-0-12-380860-8.00003-3

Source DB:  PubMed          Journal:  Adv Genet        ISSN: 0065-2660            Impact factor:   1.944


  59 in total

1.  3'-UTR-located inverted Alu repeats facilitate mRNA translational repression and stress granule accumulation.

Authors:  Terry Fitzpatrick; Sui Huang
Journal:  Nucleus       Date:  2012-06-12       Impact factor: 4.197

2.  Antagonistic and stimulative roles of ADAR1 in RNA silencing.

Authors:  Kazuko Nishikura; Masayuki Sakurai; Kantaro Ariyoshi; Hiromitsu Ota
Journal:  RNA Biol       Date:  2013-07-30       Impact factor: 4.652

3.  Splicing variants of ADAR2 and ADAR2-mediated RNA editing in glioma.

Authors:  Yao Fu; Xingli Zhao; Zhaohui Li; Jun Wei; Yu Tian
Journal:  Oncol Lett       Date:  2016-06-15       Impact factor: 2.967

4.  REDIportal: a comprehensive database of A-to-I RNA editing events in humans.

Authors:  Ernesto Picardi; Anna Maria D'Erchia; Claudio Lo Giudice; Graziano Pesole
Journal:  Nucleic Acids Res       Date:  2016-09-01       Impact factor: 16.971

5.  ADARB1 catalyzes circadian A-to-I editing and regulates RNA rhythm.

Authors:  Hideki Terajima; Hikari Yoshitane; Haruka Ozaki; Yutaka Suzuki; Shigeki Shimba; Shinya Kuroda; Wataru Iwasaki; Yoshitaka Fukada
Journal:  Nat Genet       Date:  2016-11-28       Impact factor: 38.330

Review 6.  Alu elements: know the SINEs.

Authors:  Prescott Deininger
Journal:  Genome Biol       Date:  2011-12-28       Impact factor: 13.583

Review 7.  Protein kinase PKR and RNA adenosine deaminase ADAR1: new roles for old players as modulators of the interferon response.

Authors:  Christian K Pfaller; Zhiqun Li; Cyril X George; Charles E Samuel
Journal:  Curr Opin Immunol       Date:  2011-09-15       Impact factor: 7.486

Review 8.  Post-transcriptional regulation of LINE-1 retrotransposition by AID/APOBEC and ADAR deaminases.

Authors:  Elisa Orecchini; Loredana Frassinelli; Silvia Galardi; Silvia Anna Ciafrè; Alessandro Michienzi
Journal:  Chromosome Res       Date:  2018-02-02       Impact factor: 5.239

Review 9.  Transcriptomic changes in brain development.

Authors:  Allissa A Dillman; Mark R Cookson
Journal:  Int Rev Neurobiol       Date:  2014       Impact factor: 3.230

10.  Mutations in ADAR1 cause Aicardi-Goutières syndrome associated with a type I interferon signature.

Authors:  Gillian I Rice; Paul R Kasher; Gabriella M A Forte; Niamh M Mannion; Sam M Greenwood; Marcin Szynkiewicz; Jonathan E Dickerson; Sanjeev S Bhaskar; Massimiliano Zampini; Tracy A Briggs; Emma M Jenkinson; Carlos A Bacino; Roberta Battini; Enrico Bertini; Paul A Brogan; Louise A Brueton; Marialuisa Carpanelli; Corinne De Laet; Pascale de Lonlay; Mireia del Toro; Isabelle Desguerre; Elisa Fazzi; Angels Garcia-Cazorla; Arvid Heiberg; Masakazu Kawaguchi; Ram Kumar; Jean-Pierre S-M Lin; Charles M Lourenco; Alison M Male; Wilson Marques; Cyril Mignot; Ivana Olivieri; Simona Orcesi; Prab Prabhakar; Magnhild Rasmussen; Robert A Robinson; Flore Rozenberg; Johanna L Schmidt; Katharina Steindl; Tiong Y Tan; William G van der Merwe; Adeline Vanderver; Grace Vassallo; Emma L Wakeling; Evangeline Wassmer; Elizabeth Whittaker; John H Livingston; Pierre Lebon; Tamio Suzuki; Paul J McLaughlin; Liam P Keegan; Mary A O'Connell; Simon C Lovell; Yanick J Crow
Journal:  Nat Genet       Date:  2012-09-23       Impact factor: 38.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.